Getting the right medicine to the right patient at the right time.
Joined March 2010
- Tweets 1,384
- Following 1,203
- Followers 1,395
- Likes 206
388 Photos and videos
📢 Exciting news! 🎉Today, we unveiled a strengthened leadership team. A warm welcome to Jerome Charton as CEO, and Michael Mensa as CFO. #Clinigen #Leadership #PharmaServices
clinigengroup.com/news/news-…
2
2
537
With an ambition to achieve net zero emissions by 2040 and a significant reduction as early as 2030, Clinigen is proud to announce its commitment to the Science Based Targets initiative (SBTi).
@ScienceTargets #ScienceBasedTargets #SBTiCommitment #ClimateResponsibility
1
408
We are proud to sponsor an all expert session on the current issues in the optimisation of Asparaginase use in clinical practice at @SIOPEurope, Tuesday 9th May 2023.
Register now to join us in Valencia.
siopeurope.eu/
2
5
750
Clinigen Insights 2023 – We are live!
Should Early Access be considered an integral part of a market access strategy?
Today and tomorrow, we’ll discuss this key topic and more at our Clinigen Insights event in Basel, Switzerland.
#earlyaccess #managedaccess #expandedaccess
1
295
We’re pleased to announce that Clinigen has entered into an agreement to divest Lamda Laboratories to Adragos Pharma.
Read the press release in full:
clinigengroup.com/news/news-…
279
Final call for our free-to-attend 'Clinigen Insights Conference' with keynote speaker Tim Spector, Professor at King’s College London and co-founder of Zoe Ltd.
Have a look at the full event agenda and register to attend: bit.ly/3YnOqk1
222
Managed Access as part of a commercial strategy -
Join our free-of-charge Clinigen Insights event to learn what needs to be considered:
bit.ly/3YnOqk1
Guest speakers include Shirle Zajac, Teva, Winston Smit, BristolMyersSquibb, Chris Hoyle & Joubert Gama, Immunocore.
256
This #InternationalWomensDay2023 we're celebrating the incredible women at Clinigen.
With 60% of our global workforce, and 60% of our Clinigen Management Academy graduates, identifying as female, we're immensely proud to provide an inclusive environment where women can thrive.
195
What are the recent changes in trends for #earlyaccess, and how can the updated regulatory framework in countries like France impact your #managedaccess strategy?
Join us at our Clinigen Insights conference next month to learn more: bit.ly/3YnOqk1
189
New @DiversityRare & @RareDiseases survey aims to uncover gaps & barriers experienced by underrepresented communities.
Together, we can identify and combat longstanding barriers experienced by the #RareDisease community!
Participate and pass on: rarediseasediversitysurvey.o…
163
There are over 300 million people, across the globe, living with rare diseases. That’s 5% of the worldwide population.
We are supporting the day by showing our colours and highlighting the great work #rarediseaseday does in helping those across the world.
#rarediseaseday2023
2
273
We're delighted to have @timspector, Professor at King’s College London and co-founder of Zoe Ltd., as keynote speaker at our Clinigen Insight conference in Basel next month: tim-spector.co.uk/
Learn more about our event and register to join: bit.ly/3YnOqk1
154
Together with guest speaker @mark_sheehan_ox, Associate Professor at the University of Oxford, we'll discuss how #patientengagement and ethical considerations can be integrated into the planning of a MAP.
Join our Clinigen Insights conference next month: bit.ly/3YnOqk1
2
680
Clinigen Insights: Together with Florence Barkats, Chief Commercial Officer at CISIV, we will present examples of real-world data collection and how #RealWorldEvidence can add value to market access.
Join our Clinigen Insights event to learn more: bit.ly/3YnOqk1
154
Clinigen is delighted to announce it has entered into an agreement to divest Proleukin® to Iovance Biotherapeutics for £166.7 million.
The deal includes a £41.7 million milestone payment and double-digit Proleukin® global sales royalties.
Find out more:
clinigengroup.com/news/news-…
232
Clinigen is excited to announce they have entered into an agreement with Accord Healthcare to initiate a Managed Access Program in Europe for relugolix (ORGOVYX®).
#managedaccess #earlyaccess
206
Join us next year as we will be hosting our Clinigen Insights conference in Basel, Switzerland, on 23-24 March 2023, following BIO-Europe Spring 2023.
Discover more and RSVP: clinigengroup.com/clinigen-i…
#managedaccess #expandedaccess
4
Clinigen are excited to announce the acquisition of Drug Safety Navigator, a specialist Pharmacovigilance service provider based in the US.
Read the press release in full:
clinigengroup.com/news/news-…
#healthcare #clinigen #pharmacovigilance
Join our Clinigen Insights conference from 23-24 March 2023 in Basel, Switzerland.
During 1.5 days this exclusive forum led by industry experts will cover key topics around managed access.
Learn more here: bit.ly/3gBbZp9
#earlyaccess #managedaccess #expandedaccess
1